MD Anderson Cancer Center Madrid - Hospiten has been included in "The Forbes List", the prestigious ranking of the magazine that recognizes the best hospitals by specialty in Spain, standing out in the category of Medical Oncology. The recognition is awarded after a rigorous in-depth analysis that evaluated more than 700 hospitals in Spain.
This distinction highlights the oncology hospital's commitment to medical excellence and continuous improvement in cancer treatment. In the words of Dr. Santiago Gonzalez-Moreno, medical director of MD Anderson Madrid - Hospiten: "We are proud to share that we have been recognized by Forbes Spain as one of the best hospitals in the country in the area of Medical Oncology. This achievement highlights our commitment to clinical excellence, therapeutic innovation and patient-centered care, thanks to the tireless work of a specialized multidisciplinary team".
The ranking analyzes centers from all over Spain taking into account criteria such as different national and international indexes, clinical results, the most relevant awards, the latest milestones achieved by each center and quality in patient care. Inclusion on the Forbes list reinforces MD Anderson Madrid - Hospiten's position as a reference in oncology in Spain.
For patients, this recognition endorses the trust they place in the hospital and its capacity to offer cutting edge therapies and a comprehensive, personalized approach to their oncology care and treatment. The hospital's connection with MD Anderson Cancer Center in Houston, one of the world leaders in cancer research and treatment, represents a guarantee of quality at every stage of cancer treatment, since its experience, medical protocols and standards of excellence are transferred to clinical practice in Madrid.
Commitment to excellence and the future of oncology in Spain.
The success of MD Anderson Madrid - Hospiten is based on a hospital structure that integrates advanced oncology surgery - dealing with more than 30 types of tumors -, precision radiotherapy and immunotherapy. It also has a Phase I Clinical Trials Unit that allows access to innovative therapies in which the center is a reference, such as adaptive radiotherapy and minimally invasive surgery.
But beyond technology, what sets the center apart is its medical team, made up of more than 150 specialists, who accompany the patient through all stages of the oncology process. MD Anderson Madrid - Hospiten reaffirms its commitment to medical excellence through research, continuous training, participation in clinical trials and the implementation of state-of-the-art treatments.
This article is an English translation generated with AI from the original Spanish content. While we review content for clarity, the information is provided for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis or treatment.